Quintiles, Inc. (Q) Recognized As Industry Leader In Phase II/III Research For Second Year In A Row
4/17/2014 9:53:22 AM
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--For the second year in a row, Quintiles has been named the industry leader that best differentiates itself on service quality for Phase II/III research in Industry Standard Research’s (ISR) 2014 CRO Quality Benchmarking Phase II/III Service Providers Report. According to the 148 pharmaceutical and biotechnology decision makers surveyed by ISR in this year’s report, Quintiles is the preferred provider for Phase II/III research among small, mid-size and large biopharmaceutical companies.
Help employers find you! Check out all the jobs and post your resume.
comments powered by